MedPath

To see effect of 3 different treatment modalities for white patch in oral cavity

Phase 4
Completed
Conditions
Health Condition 1: K132- Leukoplakia and other disturbancesof oral epithelium, including tongueHealth Condition 2: null- Oral Leukoplakia
Registration Number
CTRI/2016/12/007571
Lead Sponsor
Maulana Azad Institute of Dental Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
84
Inclusion Criteria

Patients with white lesion or mixed red and white lesion of oral mucosa clinically diagnosed as leukoplakia based on criteria from World Health Organization

Exclusion Criteria

1. Any white patch caused by friction

2. Patients with severe systemic disease including pregnant women, respiratory, cardiovascular, renal & hepatic disease

3. Those not willing to Participate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response was graded based on size of lesion as: <br/ ><br>1. Complete response: gross response revealed no evidence of lesion for at least 4 weeks (approx. 100%) <br/ ><br>2. Partial response: decrease of less than 50% of the lesion size (approx. 50%) <br/ ><br>3. Stable response: no response or no change in size of lesion <br/ ><br>4. Disease progression: unequivocal increase in size of lesion or appearance of a new lesion. <br/ ><br>Timepoint: Response was graded based on size of lesion as: <br/ ><br>1. Complete response: gross response revealed no evidence of lesion for at least 4 weeks (approx. 100%) <br/ ><br>2. Partial response: decrease of less than 50% of the lesion size (approx. 50%) <br/ ><br>3. Stable response: no response or no change in size of lesion <br/ ><br>4. Disease progression: unequivocal increase in size of lesion or appearance of a new lesion. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To report any malignant transformation or conversion to malignancy at any time during 9 months follow upTimepoint: Regular follow up was done at interval of 4 weeks upto 9 months. Any suspicious lesion was biopsied at interim stage.
© Copyright 2025. All Rights Reserved by MedPath